Objective: This retrospective service evaluation investigated the impact of engagement with an app-based digital weight loss program on weight loss outcomes among individuals using GLP-1 receptor ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Timing matters. AARP can help you understand when and how to ...

Abstract: The input-series–output-parallel (ISOP) dc/dc converter is ideal for applications requiring high input voltage and large output current. Ensuring proper input voltage sharing across the ...

Abstract: A high-gain DC-DC booster converter using a changing inductor and capacitors is described in this study for usage in solar microgrids. The suggested converter effectively boosts its ...

This library was created to read the UID of tags presented to a PN5180 RFID reader, such as below: The PN5180 implements the ISO15693 "vicinity" protocol, which typically enables tags to be read at a ...

Rumors about the astonishing weight loss potential of Eli Lilly's triple hormone drug retatrutide have been circulating for months. The results of its Phase 3 clinical trial, just released by the ...

Retatrutide, a powerful experimental weight-loss drug that mimics three different hormones the body produces after eating, helped people lose 70 pounds on average, or 28% of their body weight, ...

As Eli Lilly looks to hold its lead in the lucrative obesity market, the company’s next-gen prospect, the triple-G drug retatrutide, has met the primary endpoint for weight loss in another pivotal ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...